MUCOADHESIVE MICROCAPSULES OF INDOMETHACIN: EVALUATION FOR CONTROLLED RELEASE AND ULCEROGENIC ACTIVITY
Abstract
Mucoadhesive microcapsules of indomethacin were prepared by an emulsification-ionic gelation process employing sodium carboxy methylcellulose, methylcellulose, Carbopol and hydroxy propyl methyl cellulose along with alginate and the microcapsules were evaluated for release kinetics and ulcerogenic activity. The resulting microcapsules were discrete, free flowing, multinucleate, monolithic and spherical. Microencapsulation efficiency was 41-70 % and relatively high with alginate-sodium carboxymethylcellulose. Indomethacin release from these mucoadhesive microcapsules was found to be slow and extended over longer periods of time and depended on the composition of coat and size of the microcapsules. Drug release was diffusion controlled and followed first order kinetics. Alginate-methyl cellulose and alginate-sodium carboxymethylcellulose microcapsules were found suitable for oral controlled release. The microcapsules exhibited good mucoadhesive property in the in vitro wash-off test. Release from some microcapsules fulfilled the official (USP 23) drug release test-2 requirement of indomethacin extended release capsules. A 62-80 % reduction in ulcerogenic activity was observed with these microcapsules when compared to pure drug indomethacin.
Keywords:
mucoadhesive microcapsules, indomethacin, controlled release, ulcerogenic activity.DOI
https://doi.org/10.25004/IJPSDR.2009.010204References
Ballard BE, In: Robinson JR. eds., An overview of prolonged action drug dosage form, in sustained and controlled release drug delivery systems. Inc. New York, NY: Marcel Dekker, 1978, 22.
Kondo A, ed. Microcapsule Processing and Technology. New York, NY: Marcel Dekker; 1979, 18.
Gutcho MH, ed. Microcapsules and Microencapsulation Techniques. Park Ridge, NJ: Noyes Data Corporation; 1976, 236.
Ikeda K, Murata K, Kobayashi M, Noda K. Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull 1992; 40(8): 2155-2158.
Nagai T, Nishimoto Y, Nambu N, Suzuki Y, Sekine K. Powder dosage forms of insulin for nasal administration. J Control Release 1984; 1: 15-22.
Illum L, Farraj NF, Critcheley H, Davis SS. Nasal administration of gentamicin using a novel microsphere delivery system. Int J Pharm 1988; 46: 261-265.
Gavini E, Sanna V, Juliano C, Bonferoni MS, Giunchedi P. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine. AAPS PharmSci Tech 2002; 3: 20.
Chowdary KPR, Srinivas L. Mucoadhesive drug delivery systems: a status of current review. Indian Drugs 2000; 37: 400-406.
Chowdary KPR, Srinivasa Rao Y. Preparation and evaluation of mucoadhesive microcapsules of indomethacin. Indian J Pharm Sci 2003; 65: 49-52.
Sakagami M, Kinoshita W, Sakon K, Sato JI, Makino Y. Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. J Control Release 2002; 80: 207-218.
Takishima J, Onishi H, Machida Y. Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats. Biol Pharm Bull 2002; 25: 1498-1502.
Lim ST, Forbes B, Berry DJ, Martin GP, Brown MB. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int J Pharm 2002; 231: 73-82.
Cuna M, Alonso MJ, Torres D. Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxicillin-resin complexes for drug delivery to the gastric mucosa. Eur J Pharm Biopharm 2001; 51: 199-205.
Chowdary KPR, Srinivasa Rao Y. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release. AAPS PharmSci Tech 2003; 4: 39.
Longer M A. Robinson J R. Fundamentals of bioadhesion. Pharmacy International 1986; 7: 114-117.
Insel PA. In: Hardman JG, Limbard LE, Molinoff PB, Ruddon RW, Gilman AG, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 9th Ed. New York, NY: McGraw- Hill; 1996, 633.
Kim CK, Lee EJ. The controlled release of blue dextran from alginate beads. Int J Pharm 1992; 79: 11-19.
Hari PC, Chandy T, Sharma CP. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J Microencapsul 1996; 13: 319-329.
The United States Pharmacopeia, XXIII. Rockville, MD: United States Pharmacopeial Convention, Inc; 1995: 801.
Lehr CM, Bowstra JA, Tukker JJ, Junginer HE. Intestinal transit of bioadhesive microspheres in an in situ loop in the rat. J Control Release 1990; 13: 51-62.
Okabe S, Takeuchi K, Kakamura K, Takagi K. Evaluation of ulcerogenic activity of substances. Jap J Pharmacol 1974; 24: 363-365.
Anderson W, Soman, PD. Biological and toxicological evaluation of anti-inflammatory drugs. J Pharm Pharmacol 1965; 17: 92-95.
Published
Abstract Display: 266 
PDF Downloads: 354 
